Alessandria Biobank - Azienda Ospedaliera SS Antonio e Biagio - Alessandria - Italy, Italy

Registration Status: Completed

Objective: The Alessandria Biobank is configured as a service provider, non-profit unit aimed at the collection, preservation and distribution of biological samples for scientific research purposes by guaranteeing the rights of the subjects involved. The Alessandria Biobank is inspired by and based on ethical principles, guidelines, national and international legal frameworks concerning the protection of the privacy of the patient/donor. The Alessandria Biobank relies on the collaboration with the internal Scientific Committee, appointed to evaluate the scientific projects requesting for biological materials, to assess the priority of projects, to potentially approve requests to make biological material available for research purposes, and to discuss and evaluate, whenever necessary, contingent and specific problems concerning the whole organization and its activities.

Registered Biobank Name	Alessandria Biobank - Azienda Ospedaliera SS Antonio e Biagio - Alessandria - Italy
Biobank Leader	Libener Roberta
Country	Italy
Email for biobank inquiries	rlibener@ospedale.al.it
Principal Investigator	Libener Roberta
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).